ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1

Human Molecular Genetics

Volumn 24, Issue 9, 2015, Pages 2565-2577

  Gilpin, Kathleen M ^a   Chang, Lydia ^a   Monteiro, Mervyn J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; MUTANT PROTEIN; NUCLEAR PROTEIN; PROTEIN; UBIQUILIN 2; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; HNRNP A1; HYBRID PROTEIN; PROTEIN BINDING; UBIQUITIN; UBQLN2 PROTEIN, HUMAN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ARTICLE; CELL DEATH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; GENE; GENE LIBRARY; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MISSENSE MUTATION; NONHUMAN; OSMOTIC STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; TURNOVER TIME; TWO HYBRID SYSTEM; UBQLN2 GENE; WILD TYPE; ALLELE; AMINO ACID SUBSTITUTION; CELL LINE; GENETICS; INTRACELLULAR SPACE; METABOLISM; MUTATION; OSMOTIC PRESSURE; PROTEIN STABILITY; PROTEIN TRANSPORT;

ALLELES; AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; CELL CYCLE PROTEINS; CELL DEATH; CELL LINE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; INTRACELLULAR SPACE; MUTATION; OSMOTIC PRESSURE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STABILITY; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITINS;

EID: 84936858964     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv020     Document Type: Article

References (31)

1. Ferraiuolo, L., Kirby, J., Grierson, A.J., Sendtner, M. and Shaw, P.J. (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol., 7, 616-630.
2. Ling, S.C., Polymenidou, M. and Cleveland, D.W. (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron, 79, 416-438.
3. Robberecht, W. and Philips, T. (2013) The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci., 14, 248-264.
4. Kim, H.J., Kim, N.C., Wang, Y.D., Scarborough, E.A., Moore, J., Diaz, Z., MacLea, K.S., Freibaum, B., Li, S., Molliex, A. et al. (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature, 495, 467-473.
5. Deng, H.X., Chen, W., Hong, S.T., Boycott, K.M., Gorrie, G.H., Siddique, N., Yang, Y., Fecto, F., Shi, Y., Zhai, H. et al. (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature, 477, 211-215.
6. Williams, K.L., Warraich, S.T., Yang, S., Solski, J.A., Fernando, R., Rouleau, G.A., Nicholson, G.A. and Blair, I.P. (2012) UBQLN2/ ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol. Aging, 33, 2527 e2523-2510.
7. Fahed, A.C., McDonough, B., Gouvion, C.M., Newell, K.L., Dure, L.S., Bebin, M., Bick, A.G., Seidman, J.G., Harter, D.H. and Seidman, C.E. (2014) UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration. Ann. Neurol., 75, 793-798.
8. Lattante, S., Le Ber, I., Camuzat, A., Pariente, J., Brice, A. and Kabashi, E. (2013) Screening UBQLN-2 in French frontotemporal lobar degeneration and frontotemporal lobar degeneration-amyotrophic lateral sclerosis patients. Neurobiol. Aging, 34, 2078 e2075-2076.
9. McLaughlin, R.L., Kenna, K.P., Vajda, A., Byrne, S., Bradley, D. G. and Hardiman, O. (2014) UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland. Neurobiol. Aging, 35, 267 e269-211.
10. Rothenberg, C. and Monteiro, M.J. (2010) Ubiquilin at a crossroads in protein degradation pathways. Autophagy, 6, 979-980.
11. Lee, D.Y. and Brown, E.J. (2012) Ubiquilins in the crosstalk among proteolytic pathways. Biol. Chem., 393, 441-447.
12. Wu, A.L., Wang, J., Zheleznyak, A. and Brown, E.J. (1999) Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane. Mol. Cell, 4, 619-625.
13. Mah, A.L., Perry, G., Smith, M.A. and Monteiro, M.J. (2000) Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J. Cell Biol., 151, 847-862.
14. Kleijnen, M.F., Shih, A.H., Zhou, P., Kumar, S., Soccio, R.E., Kedersha, N.L., Gill, G. and Howley, P.M. (2000) The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol. Cell, 6, 409-419.
15. Kaye, F.J., Modi, S., Ivanovska, I., Koonin, E.V., Thress, K., Kubo, A., Kornbluth, S. and Rose, M.D. (2000) A family of ubiquitin-like proteins binds the ATPase domain of Hsp70-like Stch. FEBS Lett., 467, 348-355.
16. Lim, P.J., Danner, R., Liang, J., Doong, H., Harman, C., Srinivasan, D., Rothenberg, C., Wang, H., Ye, Y., Fang, S. et al. (2009) Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. J. Cell Biol., 187, 201-217.
17. Xia, Y., Yan, L.H., Huang, B., Liu, M., Liu, X. and Huang, C. (2013) Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradation. J. Neurochem., 129, 99-106.
18. Dreyfuss, G., Matunis, M.J., Pinol-Roma, S. and Burd, C.G. (1993) hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem., 62, 289-321.
19. Dreyfuss, G., Kim, V.N. and Kataoka, N. (2002) Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell Biol., 3, 195-205.
20. Ko, H.S., Uehara, T., Tsuruma, K. and Nomura, Y. (2004) Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains. FEBS Lett., 566, 110-114.
21. Kleijnen, M.F., Alarcon, R.M. and Howley, P.M. (2003) The ubiquitin-associated domain of hPLIC-2 interacts with the proteasome. Mol. Biol. Cell, 14, 3868-3875.
22. Massey, L.K., Mah, A.L., Ford, D.L., Miller, J., Liang, J., Doong, H. and Monteiro, M.J. (2004) Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins. J. Alzheimers Dis., 6, 79-92.
23. Pesiridis, G.S., Lee, V.M. and Trojanowski, J.Q. (2009) Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet., 18, R156-R162.
24. Lagier-Tourenne, C., Polymenidou, M. and Cleveland, D.W. (2010) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet., 19, R46-R64.
25. Da Cruz, S. and Cleveland, D.W. (2011) Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol., 21, 904-919.
26. Pinol-Roma, S. and Dreyfuss, G. (1992) Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature, 355, 730-732.
27. Allemand, E., Guil, S., Myers, M., Moscat, J., Caceres, J.F. and Krainer, A.R. (2005) Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock. Proc. Natl. Acad. Sci. USA, 102, 3605-3610.
28. Cassel, J.A. and Reitz, A.B. (2013) Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: characterization of inhibition by nucleic acids and 4-aminoquinolines. Biochim. Biophys. Acta, 1834, 964-971.
29. Stabler, S.M., Ostrowski, L.L., Janicki, S.M. and Monteiro, M.J. (1999) A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein. J. Cell Biol., 145, 1277-1292.
30. Monteiro, M.J. and Mical, T.I. (1996) Resolution of kinase activities during the HeLa cell cycle: identification of kinases with cyclic activities. Exp. Cell Res., 223, 443-451.
31. Li, M., Brooks, C.L., Wu-Baer, F., Chen, D., Baer, R. and Gu, W. (2003) Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science, 302, 1972-1975.